Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man
- PMID: 971716
- DOI: 10.1007/BF00561668
Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man
Abstract
A previously described GLC method has been modified and applied to measurement of antipyrine levels in plasma, blood and saliva of man following administration of a single oral dose (10 mg/kg). Tery time studied. The half-life of antipyrine determined in blood, plasma or saliva in any given individual was similar. The intersubject variation in half-life was about two-fold (n = 5). Antipyrine levels in saliva were not affected by the rate of saliva flow when collections were made continuously for 20 minutes. This study has demonstrated that kinetic data about antipyrine comparable to that from plasma may also be obtained from readily accessible tissue fluids, such as saliva and capillary blood.
Similar articles
-
Elimination of antipyrine from saliva as a measure of metabolism in man.Clin Pharmacol Ther. 1975 Sep;18(3):249-58. doi: 10.1002/cpt1975183249. Clin Pharmacol Ther. 1975. PMID: 1164815
-
A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.Clin Exp Pharmacol Physiol. 1977 Nov-Dec;4(6):593-6. doi: 10.1111/j.1440-1681.1977.tb02691.x. Clin Exp Pharmacol Physiol. 1977. PMID: 589875
-
Assessment of antipyrine kinetics by measurement in saliva.Br J Clin Pharmacol. 1976 Apr;3(2):321-5. doi: 10.1111/j.1365-2125.1976.tb00610.x. Br J Clin Pharmacol. 1976. PMID: 973966 Free PMC article.
-
Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.Clin Pharmacol Ther. 1975 Sep;18(3):259-72. doi: 10.1002/cpt1975183259. Clin Pharmacol Ther. 1975. PMID: 1164816
-
Therapeutic Properties of Antipyrine.Daniels Tex Med J. 1887 Mar;2(9):371-372. Daniels Tex Med J. 1887. PMID: 36952804 Free PMC article. Review. No abstract available.
Cited by
-
Effect of vitamin C supplement on antipyrine disposition in man.Br J Clin Pharmacol. 1977 Apr;4(2):236-9. doi: 10.1111/j.1365-2125.1977.tb00701.x. Br J Clin Pharmacol. 1977. PMID: 861139 Free PMC article. No abstract available.
-
Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.Br J Clin Pharmacol. 1985 Dec;20(6):611-8. doi: 10.1111/j.1365-2125.1985.tb05119.x. Br J Clin Pharmacol. 1985. PMID: 4091993 Free PMC article.
-
Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.Clin Pharmacokinet. 1992 Jul;23(1):10-29. doi: 10.2165/00003088-199223010-00002. Clin Pharmacokinet. 1992. PMID: 1617856 Review.
-
Therapeutic drug monitoring in saliva.Clin Pharmacokinet. 1978 Jan-Feb;3(1):39-57. doi: 10.2165/00003088-197803010-00003. Clin Pharmacokinet. 1978. PMID: 25155 Review. No abstract available.
-
Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.Br J Clin Pharmacol. 1979 Dec;8(6):529-37. doi: 10.1111/j.1365-2125.1979.tb01040.x. Br J Clin Pharmacol. 1979. PMID: 533575 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources